The Dietary Supplement Listing Act of 2026 aims to enhance transparency and access to information about dietary supplements in the United States. By requiring that all dietary supplements sold in the country be officially registered with the Food and Drug Administration (FDA), the law seeks to improve regulation and consumer awareness regarding these products.